Calcium

Calcium

Common Names

  • Calcium carbonate
  • Calcium citrate
  • Calcium gluconate

Jump to:

For Patients & Caregivers

Adequate calcium intake may help prevent osteoporosis, bone fracture, and colorectal cancer. However, higher calcium intake may increase the risk of cardiovascular events and prostate cancer.

Calcium plays several essential roles in the human body. It is a main structural element in bone, which acts as a reservoir for calcium so that stable blood calcium levels are maintained. This is necessary for the many roles calcium plays in cells including muscle contraction, nerve transmission, blood clotting, and enzyme reactions. When calcium intake and bodily estrogen levels are low, the body takes calcium from bones and uses it for other processes, resulting in osteoporosis.

Inadequate blood calcium levels are linked to high blood pressure. Whether the use of calcium supplements can increase the risk for heart disease or cardiac events is still unclear. Adequate calcium intake may help prevent osteoporosis, bone fracture, and colorectal cancer. The links of calcium supplements to increased prostate cancer risk may occur for reasons other than the supplements themselves.

Calcium is available from a number of foods, and can be found in some antacids as well. Because the risks and benefits of calcium supplements are still unclear and calcium can interact with the absorption of a number of drugs, patients should check with their healthcare provider about whether supplementation is warranted.

  • To prevent cancer
    Many clinical studies have been performed in humans, but the consistent effects of dietary and supplemental calcium on cancer have not been determined. There does appear to be an increased risk for prostate cancer, but a decreased risk for colorectal cancer with calcium supplements. Additional studies are warranted.
  • To reduce cardiovascular disease risk
    Studies are mixed on whether calcium supplementation protects against cardiovascular disease or increases risk for this disease. Additional studies are needed to clarify under what circumstances calcium may confer benefits or risks.
  • To lower high blood pressure
    Most clinical trials have found that calcium from the diet and from supplements can have a small effect on lowering both systolic and diastolic blood pressure.
  • To prevent the progression of osteoporosis
    Some, but not all, large clinical trials have found that calcium supplementation prevents bone loss, especially in older women. Reduced bone loss may also prevent fractures.
  • You have hypothyroidism, high blood calcium levels, or low blood phosphate levels: Consult your doctor before starting calcium supplements.
  • You are taking cardiac glycosides such as digoxin: Calcium may increase the risk of irregular heartbeat.
  • You are being treated with tamoxifen: Calcium may increase the risk of abnormally high levels of calcium in the blood. This can increase the risk of kidney stones.
  • You are taking fluoroquinolone or tetracycline antibiotics: Calcium may reduce the absorption of these antibiotics into the bloodstream. Calcium should be taken 2 hours before or 1 hour after taking these medicines.
  • You are taking drugs to treat an underactive thyroid: Taking calcium carbonate within 4 hours of this drug may decrease its absorption by almost 33%.
  • You are taking iron, zinc, or magnesium: Calcium can interfere with their absorption.
  • Constipation, flatulence, chalky taste, and dry mouth; higher calcium levels in blood or urine in older women
  • Modest increased risk of urinary stones with long-term use
  • Nausea occurs rarely
  • Intake of high-dose calcium supplements (>1 g/day) can increase the risk of stroke
  • Increasing dietary calcium from a variety of foods including non-dairy sources instead of taking supplements has been associated with a lower risk of kidney stones.
  • For those requiring calcium supplementation, increasing fluid intake may reduce the risk of kidney stones.
  • Some medications such as those for gastric reflux may reduce calcium absorption.
  • Calcium may be an ingredient in some antacids.
Back to top Arrow (up) icon.Icon pointing upwards. Usually means that the containing element can be opened and closed.

For Healthcare Professionals

Oscal®, Tums®, Caltrate®, Citracal®

Calcium is an essential mineral responsible for many physiological functions in the body. It is stored in the bones and helps maintain bone structure. Calcium also plays an important role in cell signaling and muscle contraction. Dietary calcium can be found in dairy products, dark greens, legumes, nuts and fish. Natural supplements are derived from minerals, oyster shells and occasionally corals. Calcium can be found in some antacids as well.

The effects of calcium have been studied across a range of conditions including cardiovascular disease (1) (2) (3) (4) (5), osteoporosis (6), bone density loss (7), fracture prevention (8), premenstrual syndrome (9), preeclampsia (10) (11), lead poisoning (12), and various cancers (13) (14) (15).

Long-term calcium supplement use is associated with an increased risk of coronary artery calcification (77). Some studies suggest that calcium supplementation could lead to cardiovascular disease or events (1) (2) (3) (5), but other researchers have not agreed with these conclusions (16) (17) (18). In a Women’s Health Initiative sub-study, calcium plus vitamin D supplementation and hormone therapy yielded greater reductions in LDL-C than either intervention alone or placebo (81). Calcium and vitamin D supplementation may benefit postmenopausal women who do not have pre-existing risk factors such as coronary heart disease, diabetes, or hypertension (19) and large long-term studies in women did not find adverse cardiovascular associations with calcium supplementation (4) (20). However, high intakes of calcium supplements did increase cardiovascular mortality in men (21). Another study shows calcium supplement intake is associated with dementia in women after stroke (75).

There is also conflicting evidence on calcium intake or calcium plus vitamin D supplementation on bone density and fractures (22) (23) (24) (42) (53) (82). Recent US Preventive Services Task Force reports found no associations between calcium plus vitamin D supplementation and reduced falls or fracture incidence for community-dwelling older adults without known deficiencies, osteoporosis, or history of fracture (83) (84). In postmenopausal women, neither dietary calcium (25) nor calcium plus vitamin D supplementation (26) reduced hip fracture risk, although the latter study found significant reductions at 7 years (27). Subgroup analysis further suggested that supplementation along with estrogen therapy conferred additive protection against hip fractures (28). However, there appears to be no prevention benefits with calcium and vitamin D supplementation for bone mineral density loss in breast cancer patients (7) or for older adults to help prevent fractures (78). Calcium plus vitamin D mitigated bone density loss associated with antiretroviral therapy (72). In men, bone mineral density and bone loss rates were not related to dietary calcium intake (79).

Both dietary and supplemental calcium are linked with lower risk of colorectal cancer (13) (29), but had no effect on colorectal adenomas (74). For men, calcium intake is associated with increased risk for prostate cancer (30) (31); a genetic disposition for high intestinal absorption of calcium among African-American men has also been noted (32) (33). Long-term studies suggest risks associated with calcium in prostate cancers are less strong when phosphorus intake is also considered (34) (35).

For women, studies on calcium plus vitamin D supplementation to reduce various disease risks are conflicting for colorectal cancers (38) (85), all cancer types (36) (86), and mortality (26) (37). Other studies suggest benefits against hematologic (80) but not invasive cancers (39).

In general, the evidence is insufficient to assess benefits of calcium plus vitamin D supplementation for those receiving androgen deprivation therapy, aromatase inhibitors, or undergoing chemotherapy-induced menopause (7) (43) (44). Patients should consult with their oncologist or oncology healthcare team, especially since calcium supplements can interact with a number of drugs.

A proper diet to achieve a balance among nutrients including sodium, potassium, magnesium, calcium and vitamin D is important to affect risks for hypertension as well as cardiovascular and cerebrovascular events (40). The risk–benefit ratio of supplementation is likely to vary, depending on dietary calcium intake, sex, age, ethnicity, and individual risks for cardiovascular disease and osteoporosis (41) (73). Intake of high-dose calcium supplements (>1 g/day) can also increase the risk of ischemic stroke (76). Calcium and vitamin D supplementation may increase the risk for kidney stones (42) (48) (53) (84).

Milk, yogurt, cheese, egg, bread, salmon, prawns, sardines, shrimp, broccoli, spinach, kale, collards, spring greens, baked beans, chickpeas, lentils, kidney beans, soya beans, tofu, orange, almonds, sesame seeds and fortified cereals, orange juice and soy milk

  • Cancer prevention
  • Cardiovascular disease
  • Osteoporosis
  • Hypertension

Calcium plays an important role in a variety of muscular, vascular, neurological, hormonal, and enzymatic reactions throughout the body. Calcium reserves are found mostly in the bones, helping to maintain skeletal structure.

The association of supplemental but not dietary calcium with increased cardiovascular risk could be related to their differing, acute effects on serum calcium (45). Calcium supplementation may fail to compensate for renal calcium loss, resulting in increased circulatory calcium that could lead to coronary artery deposits (46). Reduced dietary calcium may cause calcium depletion in membrane storage sites resulting in less stability of vascular smooth muscle cell membranes, as optimal concentrations stabilize these membranes, inhibit calcium entry into cells, and reduce vasoconstriction (47). Other researchers suggest that gastrointestinal events associated with calcium supplements may account for an increase in self-reported cardiovascular events (18).

Observed associations of dairy with overall prostate cancer risk may be related to the modulation of vitamin D metabolism by calcium and phosphorus (15) (31). Saturated fat in whole dairy correlating with higher C-peptide concentrations, along with obesity and hyperinsulinemia are proposed for associations of whole milk with fatal prostate cancer (31). Other suggested mechanisms include increasing levels of ionized calcium in the blood, as prostate cancer cells express both calcium-sensing receptors and calcium-dependent voltage-gated channels, the stimulation of which by extracellular calcium increases prostate cancer cell growth (44) (35). In African American men, positive associations between calcium and aggressive prostate cancer have been linked to single-nucleotide polymorphisms in the CDX-2 binding site of the VDR gene (32).

  • Calcium may interfere with the absorption of iron, magnesium, and zinc (48) (49).
  • High consumption of calcium has been associated with an increased risk of prostate cancer (30) (31) (32) (34) (49) (50) and milk-alkali syndrome (51).
  • For those with chronic kidney disease, there is an increased risk of cardiovascular disease associated with calcium supplements (52).
  • Calcium and vitamin D supplementation may increase the risk for kidney stones (42) (48) (53) (84). Increasing calcium via diet rather than supplements may lower the risk (54). For those who must take calcium in supplement form, adequate fluid intake is important to help reduce this risk (55).

Patients who have hypothyroidism (56), low serum phosphate levels (57), or high serum calcium levels associated with sarcoidosis, hyperparathyroidism, hypervitaminosis D, and certain cancers (49) should consult their physicians before taking calcium supplements.

Common: Constipation, flatulence, chalky taste and dry mouth; hypercalciuria and hypercalcemia in older women (58)

Rare: Nausea (14); modest elevation in urinary tract stone formation with long-term use (27) (58) (59)

Excessive intake: Constipation, vascular and soft-tissue calcification, nephrolithiasis, hypercalciuria, hypercalcemia, increased risk for prostate cancer (48) (32) (34). Intake of high dose calcium supplements (>1 g/day) can increase the risk of ischemic stroke (76).

Case reports

  • Life-threatening hypercalcemia/milk-alkali syndrome: Confusion, nausea, vomiting, and weakness in a 64-year-old cancer survivor who took calcium-containing antacid tablets for chronic epigastric pain (60).
  • Hypercalcemia-induced pancreatitis: Due to oral calcium supplementation in a 42-year-old female (61).
  • Proton Pump Inhibitors: May significantly reduce calcium absorption (62).
  • Cardiac glycosides: Calcium may increase risk of cardiac arrhythmia, although this is based on intravenous calcium, early case reports, and animal models (64).
  • Quinolones: Calcium may reduce absorption of quinolones (65).
  • Tamoxifen: Calcium may increase the risk of hypercalcemia (66).
  • Tetracyclines: Calcium may reduce absorption of tetracyclines (67).
  • Levothyroxine (to treat hypothyroidism): Taking calcium carbonate within 4 hours of this drug may decrease its absorption by nearly one-third (68).
  • Estrogen therapy (for osteoporosis; positive interaction): Supplemental calcium and vitamin D may have additive benefits on bone health (28).
  • Iron, zinc, or magnesium: Calcium can compete or interfere with their absorption (48) (49).

  1. Li K, Kaaks R, Linseisen J, et al. Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart. Jun 2012;98(12):920-925. doi: 

  2. Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691. 

  3. Bolland MJ, Barber PA, Doughty RN, et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ. Feb 2 2008;336(7638):262-266. 

  4. Lewis JR, Zhu K, Thompson PL, et al. The effects of 3 years of calcium supplementation on common carotid artery intimal medial thickness and carotid atherosclerosis in older women: an ancillary study of the CAIFOS randomized controlled trial. J Bone Miner Res. Mar 2014;29(3):534-541. 

  5. Bolland MJ, Grey A, Gamble GD, et al. Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women’s Health Initiative (WHI) limited-access data set. Am J Clin Nutr. Oct 2011;94(4):1144-1149. 

  6. Slevin MM, Allsopp PJ, Magee PJ, et al. Supplementation with calcium and short-chain fructo-oligosaccharides affects markers of bone turnover but not bone mineral density in postmenopausal women. J Nutr. Mar 2014;144(3):297-304. 

  7. Datta M, Schwartz GG. Calcium and vitamin D supplementation and loss of bone mineral density in women undergoing breast cancer therapy. Crit Rev Oncol Hematol. Dec 2013;88(3):613-624. 

  8. Grant AM, Avenell A, Campbell MK, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet. May 7-13 2005;365(9471):1621-1628. 

  9. Thys-Jacobs S, Starkey P, Bernstein D, et al. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. Am J Obstet Gynecol. Aug 1998;179(2):444-452. 

  10. Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent preeclampsia. N Engl J Med. Jul 10 1997;337(2):69-76. 

  11. Hofmeyr GJ, Lawrie TA, Atallah AN, et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2014;6:Cd001059. 

  12. Markowitz ME, Sinnett M, Rosen JF. A randomized trial of calcium supplementation for childhood lead poisoning. Pediatrics. Jan 2004;113(1 Pt 1):e34-39.

  13. Larsson SC, Bergkvist L, Rutegard J, et al. Calcium and dairy food intakes are inversely associated with colorectal cancer risk in the Cohort of Swedish Men. Am J Clin Nutr. Mar 2006;83(3):667-673; quiz 728-669.

  14. Chlebowski RT, Johnson KC, Kooperberg C, et al. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. Nov 19 2008;100(22):1581-1591. 

  15. Kesse E, Bertrais S, Astorg P, et al. Dairy products, calcium and phosphorus intake, and the risk of prostate cancer: results of the French prospective SU.VI.MAX (Supplementation en Vitamines et Mineraux Antioxydants) study. Br J Nutr. Mar 2006;95(3):539-545.

  16. Biggs WS. Calcium supplementation: Data were misrepresented. BMJ. Feb 23 2008;336(7641):404. 

  17. Puccetti L. Calcium supplementation: Confounders were ignored. BMJ. Feb 23 2008;336(7641):403-404; author reply 404.

  18. Lewis JR, Zhu K, Prince RL. Adverse events from calcium supplementation: relationship to errors in myocardial infarction self-reporting in randomized controlled trials of calcium supplementation. J Bone Miner Res. Mar 2012;27(3):719-722. 

  19. Donneyong MM, Hornung CA, Taylor KC, et al. Risk of heart failure among postmenopausal women: a secondary analysis of the randomized trial of vitamin D plus calcium of the women’s health initiative. Circ Heart Fail. Jan 2015;8(1):49-56. 

  20. Paik JM, Curhan GC, Sun Q, et al. Calcium supplement intake and risk of cardiovascular disease in women. Osteoporos Int. Aug 2014;25(8):2047-2056.

  21. Xiao Q, Murphy RA, Houston DK, et al. Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med. Apr 22 2013;173(8):639-646.

  22. Tang BM, Eslick GD, Nowson C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet. Aug 25 2007;370(9588):657-666. 

  23. Bolland MJ, Leung W, Tai V, et al. Calcium intake and risk of fracture: systematic review. BMJ. 2015 Sep 29;351:h4580.

  24. Bischoff-Ferrari HA, Dawson-Hughes B, Baron JA, et al. Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr. Dec 2007;86(6):1780-1790.

  25. Feskanich D, Willett WC, Colditz GA. Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women. Am J Clin Nutr. Feb 2003;77(2):504-511.

  26. Cauley JA, Chlebowski RT, Wactawski-Wende J, et al. Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women’s Health Initiative. J Womens Health (Larchmt). Nov 2013;22(11):915-929. 

  27. Prentice RL, Pettinger MB, Jackson RD, et al. Health risks and benefits from calcium and vitamin D supplementation: Women’s Health Initiative clinical trial and cohort study. Osteoporos Int. Feb 2013;24(2):567-580. 

  28. Robbins JA, Aragaki A, Crandall CJ, et al. Women’s Health Initiative clinical trials: interaction of calcium and vitamin D with hormone therapy. Menopause. Feb 2014;21(2):116-123. 

  29. Keum N, Lee DH, Greenwood DC, et al. Calcium intake and colorectal adenoma risk: dose-response meta-analysis of prospective observational studies. Int J Cancer. Apr 1 2015;136(7):1680-1687. 

  30. Abid Z, Cross AJ, Sinha R. Meat, dairy, and cancer. Am J Clin Nutr. Jul 2014;100 Suppl 1:386S-393S. 

  31. Song Y, Chavarro JE, Cao Y, et al. Whole milk intake is associated with prostate cancer-specific mortality among U.S. male physicians. J Nutr. Feb 2013;143(2):189-196. 

  32. Rowland GW, Schwartz GG, John EM, et al. Calcium intake and prostate cancer among African Americans: effect modification by vitamin D receptor calcium absorption genotype. J Bone Miner Res. Jan 2012;27(1):187-194. 

  33. Rowland GW, Schwartz GG, John EM, et al. Protective effects of low calcium intake and low calcium absorption vitamin D receptor genotype in the California Collaborative Prostate Cancer Study. Cancer Epidemiol Biomarkers Prev. Jan 2013;22(1):16-24. 

  34. Giovannucci E, Liu Y, Stampfer MJ, et al. A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev. Feb 2006;15(2):203-210. 

  35. Wilson KM, Shui IM, Mucci LA, et al. Calcium and phosphorus intake and prostate cancer risk: a 24-y follow-up study. Am J Clin Nutr. Jan 2015;101(1):173-183. 

  36. Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. Jun 2007;85(6):1586-1591.

  37. Langsetmo L, Berger C, Kreiger N, et al. Calcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos). J Clin Endocrinol Metab. Jul 2013;98(7):3010-3018.

  38. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. Feb 16 2006;354(7):684-696. 

  39. Brunner RL, Wactawski-Wende J, Caan BJ, et al. The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women’s Health Initiative (WHI) calcium plus vitamin D randomized clinical trial. Nutr Cancer. 2011;63(6):827-841. 

  40. Houston M. The role of nutrition and nutraceutical supplements in the treatment of hypertension. World J Cardiol. Feb 26 2014;6(2):38-66. 

  41. Shin CS, Kim KM. The risks and benefits of calcium supplementation. Endocrinol Metab (Seoul). Mar 27 2015;30(1):27-34.

  42. Moyer VA, Force* USPST. Vitamin D and calcium supplementation to prevent fractures in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. May 7 2013;158(9):691-696.

  43. Harvie M. Nutritional supplements and cancer: potential benefits and proven harms. Am Soc Clin Oncol Educ Book. 2014:e478-486.

  44. Datta M, Schwartz GG. Calcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: a critical review. Oncologist. 2012;17(9):1171-1179. 

  45. Bristow SM, Gamble GD, Stewart A, et al. Acute effects of calcium citrate with or without a meal, calcium-fortified juice and a dairy product meal on serum calcium and phosphate: a randomised cross-over trial. Br J Nutr. Apr 8 2015:1-10.

  46. Paziana K, Pazianas M. Calcium supplements controversy in osteoporosis: a physiological mechanism supporting cardiovascular adverse effects. Endocrine. Apr 2015;48(3):776-778. 

  47. Houston MC, Harper KJ. Potassium, magnesium, and calcium: their role in both the cause and treatment of hypertension. J Clin Hypertens (Greenwich). Jul 2008;10(7 Suppl 2):3-11. 

  48. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Available at: http://www.ncbi.nlm.nih.gov/books/NBK56070/. 2011 Accessed August 11, 2014.

  49. Straub DA. Calcium supplementation in clinical practice: a review of forms, doses, and indications. Nutr Clin Pract. Jun 2007;22(3):286-296.

  50. Chan JM, Giovannucci E, Andersson SO, et al. Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden). Cancer Causes Control. Dec 1998;9(6):559-566.

  51. Patel AM, Adeseun GA, Goldfarb S. Calcium-alkali syndrome in the modern era. Nutrients. Dec 2013;5(12):4880-4893. 

  52. Heine GH, Nangaku M, Fliser D. Calcium and phosphate impact cardiovascular risk. Eur Heart J. Apr 2013;34(15):1112-1121.

  53. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. Feb 16 2006;354(7):669-683.

  54. Gralow JR, Biermann JS, Farooki A, et al. NCCN Task Force Report: Bone Health In Cancer Care. J Natl Compr Canc Netw. Aug 2013;11 Suppl 3:S1-50; quiz S51.

  55. Harris SS, Dawson-Hughes B. Effects of Hydration and Calcium Supplementation on Urine Calcium Concentration in Healthy Postmenopausal Women. J Am Coll Nutr. Apr 9 2015:1-7. 

  56. Butner LE, Fulco PP, Feldman G. Calcium carbonate-induced hypothyroidism. Ann Intern Med. Apr 4 2000;132(7):595.

  57. Rendina D, Mossetti G, De Filippo G, et al. Fibroblast growth factor 23 is increased in calcium nephrolithiasis with hypophosphatemia and renal phosphate leak. J Clin Endocrinol Metab. Mar 2006;91(3):959-963. 

  58. Gallagher JC, Smith LM, Yalamanchili V. Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women. Menopause. Nov 2014;21(11):1173-1180. 

  59. Wallace RB, Wactawski-Wende J, O’Sullivan MJ, et al. Urinary tract stone occurrence in the Women’s Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements. Am J Clin Nutr. Jul 2011;94(1):270-277.

  60. Vanpee D, Delgrange E, Gillet JB, et al. Ingestion of antacid tablets (Rennie) and acute confusion. J Emerg Med. Aug 2000;19(2):169-171.

  61. Pronisceva V, Sebastian J, Joseph S, et al. A case report on over-replacement of oral calcium supplements causing acute pancreatitis. Ann R Coll Surg Engl. Jan 2014;96(1):94e-95e.

  62. O’Connell MB, Madden DM, Murray AM, et al. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med. Jul 2005;118(7):778-781.

  63. Boonen S, Bouillon R, Haentjens P, et al. Optimizing the benefits of bisphosphonates in osteoporosis : the importance of appropriate calcium intake. Treat Endocrinol. 2006;5(6):375-383.

  64. Kanji S, MacLean RD. Cardiac glycoside toxicity: more than 200 years and counting. Crit Care Clin. Oct 2012;28(4):527-535.

  65. Bushra R, Aslam N, Khan AY. Food-drug interactions. Oman Med J. Mar 2011;26(2):77-83.

  66. Arumugam GP, Sundravel S, Shanthi P, et al. Tamoxifen flare hypercalcemia: an additional support for gallium nitrate usage. J Bone Miner Metab. 2006;24(3):243-247. 

  67. Hathcock JN. Metabolic mechanisms of drug-nutrient interactions. Fed Proc. Jan 1985;44(1 Pt 1):124-129.

  68. Mazokopakis EE, Giannakopoulos TG, Starakis IK. Interaction between levothyroxine and calcium carbonate. Can Fam Physician. Jan 2008;54(1):39.

  69. Heaney RP, Rafferty K. Carbonated beverages and urinary calcium excretion. Am J Clin Nutr. Sep 2001;74(3):343-347.

  70. Griffith LE, Guyatt GH, Cook RJ, et al. The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. Am J Hypertens. Jan 1999;12(1 Pt 1):84-92.

  71. Allender PS, Cutler JA, Follmann D, et al. Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. Ann Intern Med. May 1 1996;124(9):825-831.

  72. Overton ET, Chan ES, Brown TT, et al. Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial. Ann Intern Med. 2015 Jun 16;162(12):815-24.

  73. Reid IR, Bristow SM, Bolland MJ. Calcium supplements: benefits and risks. J Intern Med. 2015 Oct;278(4):354-68.

  74. Baron JA, Barry EL, Mott LA, et al. A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas.N Engl J Med. 2015 Oct 15;373(16):1519-30.

  75. Kern J, Kern S, Blennow K, et al. Calcium supplementation and risk of dementia in women with cerebrovascular disease. Neurology. 2016 Aug 17. pii: 10.1212/WNL.0000000000003111.

  76. de Abajo FJ, Rodríguez-Martín S, Rodríguez-Miguel A, Gil MJ.Risk of Ischemic Stroke Associated With Calcium Supplements With or Without Vitamin D: A Nested Case-Control Study. J Am Heart Assoc. 2017 May 18;6(5). pii: e005795.

  77. Anderson JJ, Kruszka B, Delaney JA, et al. Calcium Intake From Diet and Supplements and the Risk of Coronary Artery Calcification and its Progression Among Older Adults: 10-Year Follow-up of the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Heart Assoc. Oct 11 2016;5(10).

  78. Zhao JG, Zeng XT, Wang J, et al. Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis. JAMA. Dec 26 2017;318(24):2466-2482.

  79. Bristow SM, Gamble GD, Horne AM, et al. Dietary calcium intake and rate of bone loss in men. Br J Nutr. May 2017;117(10):1432-1438.

  80. Ammann EM, Drake MT, Haraldsson B, et al. Incidence of hematologic malignancy and cause-specific mortality in the Women’s Health Initiative randomized controlled trial of calcium and vitamin D supplementation. Cancer. Nov 1 2017;123(21):4168-4177.

  81. Schnatz PF, Jiang X, Aragaki AK, et al. Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women’s Health Initiative: A Randomized Controlled Trial. Obstet Gynecol. Jan 2017;129(1):121-129.

  82. Avenell A, Mak JC, O’Connell D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev. Apr 14 2014(4):Cd000227.

  83. Guirguis-Blake JM, Michael YL, Perdue LA, et al. Interventions to Prevent Falls in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. Apr 24 2018;319(16):1705-1716.

  84. Kahwati LC, Weber RP, Pan H, et al. Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. Apr 17 2018;319(15):1600-1612.

  85. Ding EL, Mehta S, Fawzi WW, et al. Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: reanalysis of Women’s Health Initiative randomized trial. Int J Cancer. Apr 15 2008;122(8):1690-1694.

  86. Lappe J, Watson P, Travers-Gustafson D, et al. Effect of Vitamin D and Calcium Supplementation on Cancer Incidence in Older Women: A Randomized Clinical Trial. JAMA. Mar 28 2017;317(12):1234-1243.

Back to top Arrow (up) icon.Icon pointing upwards. Usually means that the containing element can be opened and closed.
Back to top Arrow (up) icon.Icon pointing upwards. Usually means that the containing element can be opened and closed.
Email your questions and comments to aboutherbs@mskcc.org.

Last Updated